STRATEGIC DRUG DEVELOPMENT
Prevalere's scientific staff provides a focused rationale for clinical and non-clinical activities. We evaluate each project to position it for optimal marketing through a carefully integrated pre-clinical and clinical development plan.
We provide consultation on:
• Pharmacology
• Bioanalytics
• Pharmacokinetics
• Biomarkers
• Anti-drug antibodies
• Toxicology
We aim to identify and optimize go/no-go decision points to help emerging companies develop a comprehensive approach to development.
